BANDUNG (3/12/2019) - Another OIC member country, Senegal through the Pasteur de Dakar Institute, will participate in the Reverse Linkage (RL) program organized by the Islamic Development Bank (IsDB), Bappenas, Ministry of Health, BPOM and Bio Farma, on 2 - 6 December 2019 with the theme Development of A Reverse Linkage Project Between Senegal (Institute of Pasteur de Dakar) and Indonesia (Bio Farma) in Vaccine Production.
Previously in 2018, the program was held with the same program for the countries of Morocco and Tunisia.
According to Slamet Soedarsono, Deputy for Politics, Law, Defense and Security of Bappenas, the Reverse Linkage Program is a development cooperation between IsDB and fellow IsDB member countries that have the ability to provide proven expertise, knowledge (know-how), technology application, and best practices that are results oriented to accelerate economic and social development.
"Indonesia has expertise in the field of Biotechnology, even it has been recognized globally through the SOE famasi namely Bio Farma. Bio Farma will share its experience in making quality vaccines in accordance with the provisions and standards of WHO, and the core of this activity is to create independence among countries Muslim countries, "said Slamet Soedarsono.
Meanwhile Bio Farma's Director of Operations M. Rahman Rostan said, he was very grateful to the Government in terms of the Ministry of Health and BPOM because through these two institutions Bio Farma products could be used in more than 140 countries.
"Collaboration that has been carried out by both the Ministry of Health and BPOM has brought Bio Farma into a reference for making vaccines that are in accordance with the standards of the World Health Organization (WHO), because the global trust in RI vaccines is not only because the industry already meets global quality, also because its supervisory function is from the NRA / BPOM which has met international standards and received recognition from WHO "said Rahman.
Rahman added that the collaboration with the Ministry of Health of the Republic of Indonesia had been going well so far, especially in terms of providing vaccines for domestic vaccine needs and also the appointment of Bio Farma as a referral Laboratory for the OIC country by the Ministry of Health of the Republic of Indonesia when Indonesia was appointed as CoE by the OIC last December 2017 .
Hopefully, in the long run the RL program, Bio Farma can send researchers to OIC countries and other African countries, to share knowledge and knowledge so that African countries will be able to independently produce quality vaccines for their respective countries so that the SDGs 2030 program can achieved namely suppressing infant and maternal mortality rates and equitable access to medicine can be achieved. (Even)